Medical Economics October 6, 2023
ATA praises move, predicts ‘Super Bowl for telehealth’ coming in 2024.
Telehealth flexibilities for prescribing controlled substances will continue through 2024.
On Oct. 6, the U.S. Department of Health and Human Services (HHS) and the U.S. Drug Enforcement Administration (DEA) in the U.S. Department of Justice announced the continuation of a rule that started during the COVID-19 pandemic. Starting in March 2020, physicians were permitted to prescribe some controlled substances via telehealth without seeing patients in person.
That allowance was to end with the COVID-19 public health emergency (PHE) in May, but the federal regulators continued it until Nov. 11, six months after the end of the PHE. The Oct. 6 announcement extends the exception again through Dec. 31, 2024.
...Today's Sponsors
Today's Sponsor